BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 28645267)

  • 1. A rapid and quantitative method to detect human circulating tumor cells in a preclinical animal model.
    Tu SH; Hsieh YC; Huang LC; Lin CY; Hsu KW; Hsieh WS; Chi WM; Lee CH
    BMC Cancer; 2017 Jun; 17(1):440. PubMed ID: 28645267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.
    Tawara K; Bolin C; Koncinsky J; Kadaba S; Covert H; Sutherland C; Bond L; Kronz J; Garbow JR; Jorcyk CL
    Breast Cancer Res; 2018 Jun; 20(1):53. PubMed ID: 29898744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
    Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
    Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
    Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
    BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.
    Jenkins DE; Hornig YS; Oei Y; Dusich J; Purchio T
    Breast Cancer Res; 2005; 7(4):R444-54. PubMed ID: 15987449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three different methods for the detection of circulating tumor cells in mice with lung metastasis.
    Xu W; Wu B; Fu L; Chen J; Wang Z; Huang F; Chen J; Zhang M; Zhang Z; Lin J; Lan R; Chen R; Chen W; Chen L; Hong J; Zhang W; Ding Y; Okunieff P; Lin J; Zhang L
    Oncol Rep; 2017 Jun; 37(6):3219-3226. PubMed ID: 28498481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models.
    Cleris L; Daidone MG; Fina E; Cappelletti V
    Cells; 2019 Jul; 8(7):. PubMed ID: 31284534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic high-resolution profiling of single CKpos/CD45neg flow-sorting purified circulating tumor cells from patients with metastatic breast cancer.
    Neves RP; Raba K; Schmidt O; Honisch E; Meier-Stiegen F; Behrens B; Möhlendick B; Fehm T; Neubauer H; Klein CA; Polzer B; Sproll C; Fischer JC; Niederacher D; Stoecklein NH
    Clin Chem; 2014 Oct; 60(10):1290-7. PubMed ID: 25267515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay.
    Baccelli I; Schneeweiss A; Riethdorf S; Stenzinger A; Schillert A; Vogel V; Klein C; Saini M; Bäuerle T; Wallwiener M; Holland-Letz T; Höfner T; Sprick M; Scharpff M; Marmé F; Sinn HP; Pantel K; Weichert W; Trumpp A
    Nat Biotechnol; 2013 Jun; 31(6):539-44. PubMed ID: 23609047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
    Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating tumor cells in patients with breast cancer using the quantitative RT-PCR assay for monitoring of therapy efficacy.
    Wang HY; Ahn S; Kim S; Park S; Park S; Han H; Sohn JH; Kim S; Lee H
    Exp Mol Pathol; 2014 Dec; 97(3):445-52. PubMed ID: 25217799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytometric characterization of circulating tumor cells captured by microfiltration and their correlation to the CellSearch(®) CTC test.
    Adams DL; Stefansson S; Haudenschild C; Martin SS; Charpentier M; Chumsri S; Cristofanilli M; Tang CM; Alpaugh RK
    Cytometry A; 2015 Feb; 87(2):137-44. PubMed ID: 25515318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models.
    Adachi Y; Yoshimura M; Nishida K; Usuki H; Shibata K; Hattori M; Kondo N; Yatabe Y; Iwata H; Kikumori T; Kodera Y; Nakanishi H
    Breast Cancer Res Treat; 2018 Jan; 167(2):439-450. PubMed ID: 29027049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonality of circulating tumor cells in breast cancer brain metastasis patients.
    Riebensahm C; Joosse SA; Mohme M; Hanssen A; Matschke J; Goy Y; Witzel I; Lamszus K; Kropidlowski J; Petersen C; Kolb-Kokocinski A; Sauer S; Borgmann K; Glatzel M; Müller V; Westphal M; Riethdorf S; Pantel K; Wikman H
    Breast Cancer Res; 2019 Sep; 21(1):101. PubMed ID: 31481116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay.
    Wang HY; Ahn S; Kim S; Park S; Jung D; Park S; Han H; Sohn J; Kim S; Lee H
    Int J Clin Oncol; 2015 Oct; 20(5):878-90. PubMed ID: 25708591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.
    Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D
    Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients.
    Fina E; Cleris L; Dugo M; Lecchi M; Ciniselli CM; Lecis D; Bianchi GV; Verderio P; Daidone MG; Cappelletti V
    J Exp Clin Cancer Res; 2022 Feb; 41(1):78. PubMed ID: 35216615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proportion of circulating tumor cell clusters increases during cancer metastasis.
    Suo Y; Xie C; Zhu X; Fan Z; Yang Z; He H; Wei X
    Cytometry A; 2017 Mar; 91(3):250-253. PubMed ID: 28009470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiling of circulating tumor cells in metastatic breast cancer.
    Lang JE; Scott JH; Wolf DM; Novak P; Punj V; Magbanua MJ; Zhu W; Mineyev N; Haqq CM; Crothers JR; Esserman LJ; Tripathy D; van 't Veer L; Park JW
    Breast Cancer Res Treat; 2015 Jan; 149(1):121-31. PubMed ID: 25432738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.